GlassScriptPhysician profile
Joeli B Reim
NPI 1609500156
$3,080.91
in general payments reported to CMS, 2019-2025
10 companies · $642 in 2025
The $642 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,439 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593 · Travel and Lodging: $1,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.51 |
| Travel and Lodging | $1,488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,705.44 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Depuy Synthes Sales INC. | $883.35 | 2024-2025 | Na, Tfn-Advance, Hammerlock |
| Si-Bone, INC. | $286.35 | 2024-2025 | |
| Stryker Corporation | $46.51 | 2025 | Pangea |
| Skeletal Dynamics INC | $42.60 | 2024 | Align, Implate, Ijs |
| Mimedx Group, INC. | $27.69 | 2025 | |
| Nevro Corp. | $25.77 | 2024 | Senza |
| Solventum Corporation | $25.45 | 2024 | Prevena |
| Polynovo North America LLC | $19.84 | 2025 | Novosorb Btm |
| Organogenesis INC. | $17.91 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joeli Reim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.